Twist Bioscience Corporation (TWST) Misses Q2 EPS by 1c, Revenues Beat; Raises FY21 Revenues Guidance Above Consensus

Go back to Twist Bioscience Corporation (TWST) Misses Q2 EPS by 1c, Revenues Beat; Raises FY21 Revenues Guidance Above Consensus
(NASDAQ: TWST) Delayed: 161.49 -5.5 (3.29%)
Previous Close $166.99    52 Week High
Open $168.40    52 Week Low
Day High $170.23    P/E N/A 
Day Low $160.89    EPS
Volume 1,215,392